View our slides for an introduction to how indexing is carried out in Embase, guided examples of how indexing helps you to retrieve more comprehensive and relevant results and where you can find more information on indexing.
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
Embase: An introduction to indexing 20 October 2014
1. Embase: An introduction to
indexing
Presented by Ann-Marie Roche
22 October 2014
a.roche@elsevier.com
Embase® is a registered trademark of Elsevier BV.
2. 2
• Webinar control panel:
• ‘chat’ for questions or ‘ask a
question’
• minimize option for full screen
view
• Q&A at the end of the webinar
• The goal is to understand how
indexing works in Embase and
how it impacts your search
results.
NEED TO KNOWS
Ann-Marie Roche 22 October 2014 An introduction to indexing
3. EMBASE IS AS COMPREHENSIVE AS POSSIBLE
3
0 % 50 % 100 %
FEB 2014 | EMBASE SALES PRESENTATION
Percentage of relevant articles retrieved
Effort / tools required
GOOGLE
EMBASE
PUBMED
SOURCE
SCOPUS
TEXT
MINING
4. ANATOMY OF AN INDEX
4
Ann-Marie Roche 22 October 2014 An introduction to indexing
7. EMBASE INDEX
7
Ann-Marie Roche 22 October 2014 An introduction to indexing
8. EMBASE INDEX (DRUG SUBHEADINGS)
8
Ann-Marie Roche 22 October 2014 An introduction to indexing
9. EMBASE INDEX (DISEASE SUBHEADINGS)
9
Ann-Marie Roche 22 October 2014 An introduction to indexing
10. INDEXING NEEDS A THESAURUS
10
Focus on drugs and devices, with dynamic updating
Structure
Content Updates
Drug-rich content
• >30,000 drug terms
• ALL generics, trade names
& chemical names
Faceted structure
• natural-language
• synonym-rich
• polyhierarchical
Dynamic updating
• candidate term source list
• updates 3x each year
• all terms backposted
Medical devices
• .> 3,000 device terms
(pre-2012: <1000 terms)
For further information: http://www.embase.com/info/what-is-embase/emtree
Ann-Marie Roche 22 October 2014 An introduction to indexing
11. NOT MISSING ANY IMPORTANT INFORMATION
11
Embase Medline
Humira 16,200 4048
Enbrel 19,711 4197
Remicade 30,347 9,493
Advair 2425 264
Lantus 6101 1741
Rituxin 40,829 13,076
Avastin 35,591 1,086
FEB 2014 | EMBASE SALES PRESENTATION
12. BROWSING EMTREE TO FIND DRUG NAMES
12
Searching for Adverse reactions
BROWSE EMTREE FACETS
Ann-Marie Roche 22 October 2014 An introduction to indexing
13. 13
Searching for Adverse reactions
DRUG SEARCH
FIND A SPECIFIC DRUG TERM
Ann-Marie Roche 22 October 2014 An introduction to indexing
14. 14
adverse reactions
FIND ADVERSE EVENTS FOR CISPLATIN
Ann-Marie Roche 22 October 2014 An introduction to indexing
15. FILTER FROM LIST OF INDEXED DISEASES
15
adverse reactions to cisplatin
Ann-Marie Roche 22 October 2014 An introduction to indexing
16. ADVERSE REACTIONS TO CISPLATIN
IN-DEPTH DRUG INDEXING
16
Ann-Marie Roche 22 October 2014 An introduction to indexing
17. DEFINITIONS OF ADVERSE EVENTS
ON EMBASE AND MEDLINE
17
Embase
first 4 of >100 terms PubMed / MEDLINE
"chemicals and drugs category/adverse effects"[MeSH Terms]
NOT ("chemicals and drugs category/toxicity"[MeSH Terms]
OR "chemicals and drugs category/poisoning"[MeSH Terms])
Ann-Marie Roche 22 October 2014 An introduction to indexing
Search using:
Search using: "chemicals and drugs”/exp/dd_ae
only in humans
18. 18
Adverse reactions to cisplatin
EMBASE VS MEDLINE
Ann-Marie Roche 22 October 2014 An introduction to indexing
Embase
19. FINDING NEW DRUGS
19
Ref: http://www.news-sentinel.com/apps/pbcs.dll/article?AID=/20121115/NEWS/
121119726/-1/LIVING
Ann-Marie Roche 22 October 2014 An introduction to indexing
20. FINDING NEW DRUGS
STEP 1: IDENTIFYING THE DRUG CATEGORY
20
Ann-Marie Roche 22 October 2014 An introduction to indexing
21. FINDING NEW DRUGS
STEP 2: SEARCH USING THE DRUG CATEGORY
21
Change /exp to
/de and add
‘unclassified
drug’ (see notes)
Ann-Marie Roche 22 October 2014 An introduction to indexing
22. FINDING NEW DRUGS
STEP 3: CANDIDATE TERMS NOT FOUND IN EMTREE
22
Ann-Marie Roche 22 October 2014 An introduction to indexing
23. FINDING NEW DRUGS
IDENTIFYING TRADE NAMES AND MANUFACTURERS
23
From drug index for this article
Ann-Marie Roche 22 October 2014 An introduction to indexing
24. FINDING NEW DRUGS
STEP 4: MORE INFORMATION ON TRADE NAMES AND LAB CODES
24
Ann-Marie Roche 22 October 2014 An introduction to indexing
25. BACK-POSTING?
25
Emtree is now updated 3x each year
Terms added and changed are listed:
http://www.embase.com/info/what-is-embase/
emtree
New terms backposted to past years:
a) if indexed earlier as candidate terms
b) if previous PTs are assigned as synonyms
Ann-Marie Roche 22 October 2014 An introduction to indexing
27. SEARCHING FOR MEDICAL DEVICES
NEW TREE STRUCTURE IN 2013 AND UPDATED IN 2014
27
Ann-Marie Roche 22 October 2014 An introduction to indexing
28. SEARCHING FOR MEDICAL DEVICES
USING FILTERS TO SEARCH FOR TRADE NAMES AND COMPLICATIONS
28
Ann-Marie Roche 22 October 2014 An introduction to indexing
29. SEARCHING FOR EVIDENCE: STUDY TYPES AND
TOPIC TERMS
29
From Emtree facet “Types of article or study”
Include many more terms than check tags
Now include “Topic terms” (from 2011)
Topic terms: 10 terms ending with (topic)
Topic terms were introduced in 2011 to differentiate
between study types, indexed when the article IS the
primary report for an RCT (for example), and articles in
which that term is only a topic that is discussed.
Ann-Marie Roche 22 October 2014 An introduction to indexing
30. MEDLINE RECORDS IN EMBASE
30
Over 9m records in Embase are licensed from NLM
They currently come from over 2500 active journals
… distributed over all years (1940 – present)
280,000 recs /yr
1974
Ann-Marie Roche 22 October 2014 An introduction to indexing
31. INDEXING PRINCIPLES
31
1. TRANSLATE
To bring the semantic richness of medical terminology
within your grasp: mapping many synonyms to a single
(natural language) preferred terminology
2. EXPAND
To expose and summarize the information in biomedical
articles beyond title and abstract: discovering in-depth
data about drugs, diseases and medical devices
3. FOCUS
To identify the key concepts hidden within those articles
– what they are really about – providing you with a toolkit
to find answers beginning with comprehensive searches
Ann-Marie Roche 22 October 2014 An introduction to indexing
32. THANK YOU
ANY QUESTIONS?
32
Ann-Marie Roche 22 October 2014 An introduction to indexing
33. 33
AND FOR MORE INFORMATION …
PLEASE FILL IN THE SURVEY WHICH WILL POP UP AT THE END OF THE WEBINAR.
For more information and questions please use
Help in Embase, where you may also find all
training and support materials and our full
webinar schedule.
Our next Embase webinar is on November 26
and will focus on drug safety and device post-surveillance
searching. We hope to have a
special external guest also.
The slides and recording will be shared within
24 hours.
THANK YOU and SEE YOU NEXT TIME!
Ann-Marie Roche 22 October 2014 An introduction to indexing
Editor's Notes
First of all, I will show you how we index a typical article.
This is an indexed article in Embase, with the concepts highlighted that in one way or another are represented in the Embase indexing.
The concepts on this page come from the title and abstract …
… but if you look further into the article, for example the Methods section, you see there are quite a few index concepts that we pick up here as well …
And from the heart of the article, from tables as well as text, and from figures as well, our indexers identify important information that we think is important to index, such as (here) information about adverse drug events.
In general, Embase indexers are seeking to identify important original information that is presented in the article, rather than hypotheses or ideas that might be mentioned in the discussion.
For this article, the indexing process resulted in all the terms shown here, divided as you see into Drug terms, Disease terms, Other terms and Additional information.
At the right hand side of each of the blue bars you can “open” the drug and disease terms, which is what I will show you next.
Here first of all is the opened drug indexing.
What you see is that each of the drug terms, here identified in the light blue bars, is qualified by a number of other terms. We call these subheadings, which may be “key subheadings” or “other subheadings”. Key subheadings have additional information shown in the middle column, which we call triple links. I’ll be showing more examples of this shortly.
Here is the corresponding disease indexing.
In this case it is quite lengthy, because each of the so-called disease terms is actually a side effect of one or more drug terms.
In order to accurately and consistently index every article in Embase, our indexers use controlled vocabulary or a thesaurus called Emtree.
You can see that alongside the structural aspects shown here on the left, Emtree has a very strong focus on drugs and chemicals.
In fact more than 50% of the 60,000 or so terms in Emtree which we use for indexing – and which we call Preferred Terms – are drugs and chemicals.
We have a very active policy to identify new drugs, and include in Emtree ALL generic names for drugs registered with various agencies, as well as New Drug Approvals registered with the FDA and EMA (European Medicines Agency).
And as you can see on the right, we ensure that Emtree is updated 3x a year, including many new terms identified via our candidate terms procedure. Typically, well over 1,000 new Preferred terms are added each year to Emtree.
[Click] ... Last year, we focused especially on medical devices terminology., as I will show you in a moment in more detail.
We will look at backposting in more detail later.
Top selling drugs in 2013 compared. The trade name was searched in Quick Search in Embase (mapped to Emtree term) and from the search box in Pubmed.
You will find Emtree under ‘Browse’ in Embase. Click on ‘Browse by facet’ to get a picture of the structure. Each major branch has many, many sub-branches and you can keep clicking to get to more specific terms, such as a specific drug used to treat a specific condition or target in the body.
Click on ‘Find term’ to more quickly get to a specific term. Here we looked for cisplatin. Click on ‘Take this query to Drug Search’ to further search for this drug and add filters and subheadings.
Here we are searching for all adverse events reported for cisplatin in Embase.
We can further refine from the search results page by clicking on the ‘Disease’ filter for example.
Clicking on ‘Index terms’ in a specific article, we can find even deeper information, such as the specific side effects cited in this article for cisplatin. The indexers make a link between the drug, specific concepts such as adverse events and the disease, in this case the disease is the side effect.
So let’s look at an example of how this might work.
… and let’s suppose you are interested in developing new drugs for cystic fibrosis
In this example, I am imagining that you found an article which mentions the treatment of cystic fibrosis with a new drug: kalydeco, a chloride channel stimulator.
This might make you wonder what other similar drugs might be under development.
In Emtree, you can quickly identify kalydeco as a synonym of ivacaftor
Try looking for kalydeco in Quick Search. Even here you are prompted with what we call the ‘preferred term’ or Emtree term. Why is it the preferred Ivacaftor was added to Emtree in 2011, and is listed as a “chloride channel stimulating agents”
So are there similar drugs under development in this category for treating cystic fibrosis?
Even if they are not yet listed in Emtree, you can easily find them …
Here’s how you do it !
First of all, you can search the entire category by clicking on the link indicated by the arrow.
The result is shown here: this explosion search with /exp captures all the articles in the entire category.
What you can now do is to edit the search to retrieve only records indexed with the category name itself
To do that, you change the explosion to an exact search using /de
Why should you do this? It’s because Embase indexers index using the most specific terms in Emtree.
But if the terms they want to index are not yet covered in Emtree, they index the next best thing: its category.
In this case, that is “ion transport affecting agent”
As you can see, this already brings the number of results down.
Of course, the indexer also indexes the new drug as a candidate term
But as we don’t know what that is, we can’t search it directly.
Fortunately there is a way around this.
When he indexes a candidate drug term, there is one more thing the indexer has to do.
He also indexes the term “unclassified drug” to indicate that he has assigned a candidate term.
The first result looks quite promising, so let’s look at the index.
As you can see, quite a few drug names are listed, including ivacaftor, the drug we started with.
If you click on this (ivacaftor), you get more information about why it has been indexed in this article.
As I mentioned before, the kind of indexing we see here is called “triple indexing”, because the subheading links two other terms …
… in this case the triples are a drug linked to two other drugs, and a drug linked to a disease.
You can’t actually search on triples yet, but you can see in the actual results what is linked with what, as here.
Although you can’t see which drugs are the candidate terms here, it’s quite likely that one or more of the lab codes is in fact a candidate term.
For example, if you click on the symbol next to “n6022” you can check whether the drug is in Emtree.
In this case, ‘n 6022’ is not recognised by Emtree, so it must have been a candidate term
In a similar article, the trade names, or lab codes, are also indexed separately, together with their manufacturers.
The indexing rule is, that all these trade names are also searchable in the descriptor field as drugs.
(xx) First of all, the codes highlighted in the red box were all indexed without any change as drug terms in this article.
(you can see this by comparing the terms with the drug index at the bottom of the slide).
This means they are either Emtree preferred terms in their own right, or candidate drug terms (like vx 661).
(xx) However, the two lab codes on the right were don’t seem to have been indexed as drug terms. So what are they?
A quick check in Emtree (now searching with the letters vx) shows that they are in fact the codes for ivacaftor and lumacaftor
What happened in both cases is that the codes were mapped to their generic names; and it is the generic names that appear in the index.
Emtree is now updated 3 times each year - you can find lists of added and changed terms at the URL shown on this slide.
When we make these updates, we also reload Embase.com to update the indexing of older records whose indexing has changed.
We call this backposting.
(**) using the example we searched on earlier, we can see in Emtree that ivacaftor was introduced to Emtree in 2011
However, if you search on ivacaftor you can find records that are indexed with this term as early as 2007.
These earlier records have been backposted, and if you look at their indexes they will indeed display the current term, ivacaftor.
The value of this to you as a searcher is that you don’t need to worry about name changes in Emtree.
You can confidently search using the current version of Emtree, knowing that you will not miss any records that were indexed slightly differently in the past – they will have been backposted.
Focus on prostheses and orthoses, getting to hip prosthesis.
Embase check tags include a group of study types, such as “major clinical study” and “randomized controlled trial”.
Another way of finding study types is to use the Filters at the left hand side of the results page, which I mentioned a few moments ago.
(**) All of the study types mentioned here for one particular search are taken from the Emtree facet on “Types of article or study”
(**) This is a rich source of terms that you can use to filter your search, and it now includes 10 so-called topic terms shown here, that I described last month in an Embase webinar on Evidence Based Medicine. If you want to follow up on this, you can access those slides via the Embase info site.
This definition of topic terms, by the way, mirrors the definitions of similar terms which the NLM uses to index MEDLINE.
The last topic I want to address here is the indexing of MEDLINE records on Embase.
As you can see here, almost 9 million records on Embase.com are licensed from NLM. You can access them using the search shown here, where the records deduplicated against Embase and Embase Classic are NOT-ed out.
(**) These records are spread over all the years of Embase, including the early years before 1974 also covered by Embase Classic.
But first, let’s take a high level view of what is happening here.
Probably like all databases, Embase indexing serves three main roles: to translate (**), expand (**), and focus (**).
What is specific to Embase is how we interpret each of these aspects.
For example:
Under the heading translation, what is special about Embase is the natural language terminology used for indexing, and the very large number of synonyms.
expansion stands for the in-depth indexing of drugs, diseases and in fact also medical devices which is derived from the full text of the article
and focus refers to the specific tools that Embase makes available to help you drill down to the articles you need.